Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Sanofi (SNYNF) Total Liabilities (2016 - 2025)

Historic Total Liabilities for Sanofi (SNYNF) over the last 17 years, with Q4 2025 value amounting to $14.0 billion.

  • Sanofi's Total Liabilities fell 7635.2% to $14.0 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $14.0 billion, marking a year-over-year decrease of 7635.2%. This contributed to the annual value of $13.6 billion for FY2025, which is 7733.51% down from last year.
  • According to the latest figures from Q4 2025, Sanofi's Total Liabilities is $14.0 billion, which was down 7635.2% from $62.2 billion recorded in Q2 2025.
  • Sanofi's Total Liabilities' 5-year high stood at $62.2 billion during Q2 2025, with a 5-year trough of $14.0 billion in Q4 2025.
  • Its 5-year average for Total Liabilities is $53.6 billion, with a median of $58.2 billion in 2021.
  • In the last 5 years, Sanofi's Total Liabilities skyrocketed by 18043.48% in 2021 and then crashed by 7635.2% in 2025.
  • Quarter analysis of 5 years shows Sanofi's Total Liabilities stood at $59.0 billion in 2021, then fell by 10.16% to $53.0 billion in 2022, then rose by 6.45% to $56.4 billion in 2023, then rose by 4.75% to $59.1 billion in 2024, then crashed by 76.35% to $14.0 billion in 2025.
  • Its Total Liabilities was $14.0 billion in Q4 2025, compared to $62.2 billion in Q2 2025 and $59.1 billion in Q4 2024.